Shenzhen Mindray (China) Today
| 300760 Stock | 269.06 2.48 0.93% |
Performance5 of 100
| Odds Of DistressLess than 9
|
Shenzhen Mindray is trading at 269.06 as of the 28th of November 2024, a 0.93% up since the beginning of the trading day. The stock's open price was 266.58. Shenzhen Mindray has less than a 9 % chance of experiencing financial distress in the next few years but had a somewhat modest performance during the last 90 days. Equity ratings for Shenzhen Mindray Bio Medical are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 30th of August 2024 and ending today, the 28th of November 2024. Click here to learn more.
Business Domain Health Care Equipment & Services | Category Healthcare | Classification Health Care |
Shenzhen Mindray is entity of China. It is traded as Stock on SHE exchange. The company has 1.21 B outstanding shares. More on Shenzhen Mindray Bio Medical
Moving together with Shenzhen Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Shenzhen Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Shenzhen Mindray's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Shenzhen Mindray or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors) | ||||
Shenzhen Mindray's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Shenzhen Mindray's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Debt LevelsShenzhen Mindray can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Shenzhen Mindray's financial leverage. It provides some insight into what part of Shenzhen Mindray's total assets is financed by creditors.
| |||||
Shenzhen Mindray Bio Medical (300760) is traded on Shenzhen Stock Exchange in China and employs 18,044 people. Shenzhen Mindray is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Mega-Cap' category with a current market capitalization of 314.62 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Shenzhen Mindray's market, we take the total number of its shares issued and multiply it by Shenzhen Mindray's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Shenzhen Mindray Bio operates under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 1.21 B outstanding shares.
Shenzhen Mindray generates positive cash flow from operations, but has no cash available
Check Shenzhen Mindray Probability Of Bankruptcy
Ownership AllocationShenzhen Mindray Bio shows a total of 1.21 Billion outstanding shares. Shenzhen Mindray Bio maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Shenzhen Ownership Details
Shenzhen Mindray Bio Risk Profiles
Although Shenzhen Mindray's alpha and beta are two of the key measurements used to evaluate Shenzhen Mindray's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.28 | |||
| Semi Deviation | 2.61 | |||
| Standard Deviation | 3.49 | |||
| Variance | 12.2 |
Shenzhen Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Shenzhen Mindray without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run ETF Categories Now
ETF CategoriesList of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |
| All Next | Launch Module |
Shenzhen Mindray Corporate Management
Elected by the shareholders, the Shenzhen Mindray's board of directors comprises two types of representatives: Shenzhen Mindray inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Shenzhen. The board's role is to monitor Shenzhen Mindray's management team and ensure that shareholders' interests are well served. Shenzhen Mindray's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Shenzhen Mindray's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Cheng Minghe | MD Director | Profile | |
| Wenzhao Li | Secretary board | Profile | |
| Luntao Yin | Deputy Mang | Profile | |
| Haitao Huang | Deputy Mang | Profile | |
| Laiping Liu | Deputy Mang | Profile | |
| Hua Xu | Financial Accounting | Profile |
Other Information on Investing in Shenzhen Stock
Shenzhen Mindray financial ratios help investors to determine whether Shenzhen Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Shenzhen with respect to the benefits of owning Shenzhen Mindray security.